BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17950422)

  • 1. Complex dosing schedules for continuous intrathecal baclofen infusion.
    Krach LE; Kriel RL; Nugent AC
    Pediatr Neurol; 2007 Nov; 37(5):354-9. PubMed ID: 17950422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal baclofen infusion for ambulant children with cerebral palsy.
    Brochard S; Remy-Neris O; Filipetti P; Bussel B
    Pediatr Neurol; 2009 Apr; 40(4):265-70. PubMed ID: 19302938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion.
    Krach LE; Kriel RL; Gilmartin RC; Swift DM; Storrs BB; Abbott R; Ward JD; Bloom KK; Brooks WH; Madsen JR; McLaughlin JF; Nadell JM
    Pediatr Neurol; 2004 Mar; 30(3):163-8. PubMed ID: 15033197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of individuals with cerebral palsy receiving continuous intrathecal baclofen treatment: a matched-cohort study.
    Krach LE; Kriel RL; Day SM; Strauss DJ
    Dev Med Child Neurol; 2010 Jul; 52(7):672-6. PubMed ID: 19811519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GMFM 1 year after continuous intrathecal baclofen infusion.
    Krach LE; Kriel RL; Gilmartin RC; Swift DM; Storrs BB; Abbott R; Ward JD; Bloom KK; Brooks WH; Madsen JR; McLaughlin JF; Nadell JM
    Pediatr Rehabil; 2005; 8(3):207-13. PubMed ID: 16087555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial.
    Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Becher JG; Vles JS;
    Eur J Paediatr Neurol; 2009 May; 13(3):240-6. PubMed ID: 18595749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
    Meythaler JM; Guin-Renfroe S; Law C; Grabb P; Hadley MN
    Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous intrathecal baclofen therapy in children with cerebral palsy - when does improvement emerge?
    Ramstad K; Jahnsen R; Lofterod B; Skjeldal OH
    Acta Paediatr; 2010 Nov; 99(11):1661-5. PubMed ID: 19912148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy.
    Buonaguro V; Scelsa B; Curci D; Monforte S; Iuorno T; Motta F
    Pediatr Neurol; 2005 Aug; 33(2):110-3. PubMed ID: 16087055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and one-year efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy.
    Hoving MA; van Raak EP; Spincemaille GH; van Kranen-Mastenbroek VH; van Kleef M; Gorter JW; Vles JS;
    Eur J Paediatr Neurol; 2009 May; 13(3):247-56. PubMed ID: 18590974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases.
    Motta F; Buonaguro V; Stignani C
    J Neurosurg; 2007 Jul; 107(1 Suppl):32-5. PubMed ID: 17644918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid baclofen concentrations in patients undergoing continuous intrathecal baclofen therapy.
    Albright AL; Thompson K; Carlos S; Minnigh MB
    Dev Med Child Neurol; 2007 Jun; 49(6):423-5. PubMed ID: 17518926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled study of the effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy.
    Morton RE; Gray N; Vloeberghs M
    Dev Med Child Neurol; 2011 Aug; 53(8):736-41. PubMed ID: 21707598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of continuous intrathecal baclofen infusion in non-ambulant children with cerebral palsy.
    Miller F
    Dev Med Child Neurol; 2011 Aug; 53(8):679-80. PubMed ID: 21707603
    [No Abstract]   [Full Text] [Related]  

  • 15. Gram-negative meningitis and infections in individuals treated with intrathecal baclofen for spasticity: a retrospective study.
    Wunderlich CA; Krach LE
    Dev Med Child Neurol; 2006 Jun; 48(6):450-5. PubMed ID: 16700935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged, severe intrathecal baclofen withdrawal syndrome: a case report.
    Hansen CR; Gooch JL; Such-Neibar T
    Arch Phys Med Rehabil; 2007 Nov; 88(11):1468-71. PubMed ID: 17964889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term intrathecal baclofen: outcomes after more than 10 years of treatment.
    Mathur SN; Chu SK; McCormick Z; Chang Chien GC; Marciniak CM
    PM R; 2014 Jun; 6(6):506-513.e1. PubMed ID: 24355547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy.
    Senaran H; Shah SA; Presedo A; Dabney KW; Glutting JW; Miller F
    Spine (Phila Pa 1976); 2007 Oct; 32(21):2348-54. PubMed ID: 17906577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales.
    Motta F; Stignani C; Antonello CE
    J Pediatr Orthop; 2008 Mar; 28(2):213-7. PubMed ID: 18388717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous intrathecal baclofen administration by a fully implantable electronic pump for severe spasticity treatment: our experience.
    Guglielmino A; Sorbello M; Fazzio S; Zingale SF; Bucolo GE; PittalĂ  G; Castiglione A; Patti F; Mangiameli S
    Minerva Anestesiol; 2006 Oct; 72(10):807-20. PubMed ID: 17006418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.